Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2018, Vol. 9 Issue (4) : 674-684     DOI: 10.14336/AD.2017.1208
Orginal Article |
Hyperglycemia Alters Astrocyte Metabolism and Inhibits Astrocyte Proliferation
Li Wenjun1, Roy Choudhury Gourav1, Winters Ali1, Prah Jude1, Lin Wenping1,2, Liu Ran1, Yang Shao-Hua1,*
1Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
2Department of Orthopedic Surgery, The Second Affiliated Hospital, Fujian Medical University, Fujian Province, 362000, China
Download: PDF(1040 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Diabetes milieu is a complex metabolic disease that has been known to associate with high risk of various neurological disorders. Hyperglycemia in diabetes could dramatically increase neuronal glucose levels which leads to neuronal damage, a phenomenon referred to as glucose neurotoxicity. On the other hand, the impact of hyperglycemia on astrocytes has been less explored. Astrocytes play important roles in brain energy metabolism through neuron-astrocyte coupling. As the component of blood brain barrier, glucose might be primarily transported into astrocytes, hence, impose direct impact on astrocyte metabolism and function. In the present study, we determined the effect of high glucose on the energy metabolism and function of primary astrocytes. Hyperglycemia level glucose (25 mM) induced cell cycle arrest and inhibited proliferation and migration of primary astrocytes. Consistently, high glucose decreased cyclin D1 and D3 expression. High glucose enhanced glycolytic metabolism, increased ATP and glycogen content in primary astrocytes. In addition, high glucose activated AMP-activated protein kinase (AMPK) signaling pathway in astrocytes. In summary, our in vitro study indicated that hyperglycemia might impact astrocyte energy metabolism and function phenotype. Our study provides a potential mechanism which may underlie the diabetic cerebral neuropathy and warrant further in vivo study to determine the effect of hyperglycemia on astrocyte metabolism and function.

Keywords diabetes      astrocyte      metabolism      AMP-activated protein kinase     
Corresponding Authors: Yang Shao-Hua   
About author:

Equal contribution.

Issue Date: 01 August 2018
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Li Wenjun
Roy Choudhury Gourav
Winters Ali
Prah Jude
Lin Wenping
Liu Ran
Yang Shao-Hua
Cite this article:   
Li Wenjun,Roy Choudhury Gourav,Winters Ali, et al. Hyperglycemia Alters Astrocyte Metabolism and Inhibits Astrocyte Proliferation[J]. Aging and disease, 2018, 9(4): 674-684.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2017.1208     OR     http://www.aginganddisease.org/EN/Y2018/V9/I4/674
Figure 1.  High glucose inhibited astrocyte proliferation

A) Growth curve assay of primary astrocytes cultured in normal (5.5 mM) and high glucose (11 or 25 mM) for 2 weeks. 40,000 cells per well were seeded in 6-well plates (n=6) and cells were counted at 1 to 5 days after culture at each condition. High glucose at 25 mM significantly inhibited primary astrocyte proliferation (* p < 0.05, n=6). B) Growth curve of astrocytes with medium switched on day 2 (n=3-6). Switch normal glucose medium (5.5 mM) dramatically inhibited astrocyte proliferation. Switch high glucose medium (25 mM) to normal glucose medium had no impact on astrocyte proliferation. C) Normal glucose cultured astrocytes were seeded and cultured for 2 days before medium was replaced with normal glucose medium (5.5 mM), normal glucose medium with mannitol (Mannitol), and high glucose medium (25 mM) (n=4). Osmolarity adjusted by mannitol has no impact on growth curve assay of primary astrocyte culture. D) Normal (5.5 mM) and high glucose (25 mM) cultured astrocytes were seeded in 96-well plates and cultured for 3 days and viability was analyzed by calcein AM. High glucose significant inhibited astrocyte proliferation (* p<0.05, n=10).

Figure 2.  High glucose induced astrocyte cell cycle arrest without increasing apoptosis

A) Flow cytometry analysis of Annexin-V and PI staining of astrocytes cultured in normal (5.5 mM) and high glucose (25 mM) medium for 3 days (n=4). B) TUNEL staining (green) of astrocytes cultured in normal (5.5 mM) and high glucose (25 mM) for 3 days. Astrocytes were treated with 50 μM H2O2 for ~12 hours as positive control. Cells were counter stained with DAPI (blue). C) Astrocytes were cultured in normal (5.5 mM) and high glucose (25 mM) for 3 days. Then astrocytes were stained with PI and analysis by flow cytometry (* p<0.05 vs 5.5 mM, n=4). D) Real-time rtPCR analysis of cyclin expression in astrocytes cultured in normal (5.5 mM) and high glucose (25 mM) medium for 2 days (* p<0.05 vs 5.5 mM, n=4).

Figure 3.  High glucose altered astrocyte morphology and inhibited cell migration

A) GFAP staining of astrocytes cultured in normal (5.5 mM) and high glucose (25 mM) for 3 days. Nucleus was stained by DAPI. B) Western blot analysis of GFAP expression in astrocytes cultured in normal (5.5 mM) and high glucose (25 mM) for 2 weeks (n=4). C) Astrocytes were maintained in normal (5.5 mM) and high glucose (25 mM) medium for 2 weeks and then seeded for scratch assay. Cells were staining with calcein AM and fluorescent images were obtained.

Figure 4.  High glucose enhanced astrocyte glycolysis

Seahorse extracellular flux analysis of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) after 6-hour (A) and 24-hour culture (B) in normal (5.5 mM) and high glucose (25 mM) (* p<0.05 vs 5.5 mM, n=5-6). C) Real-time rtPCR analysis of HEKs and MCT1 expression of astrocytes after 24-hour culture in normal (5.5 mM) and high glucose (25 mM) (* p<0.05 vs 5.5 mM, n=6-8).

Figure 5.  High glucose increased ATP content and glycogen storage

A) Total ATP level of astrocytes after 24- and 48-hour culture in normal (5.5 mM) and high glucose (25 mM) (*p<0.05 vs 5.5 mM, n=4). B) Cellular ATP level of astrocytes after 72-hour culture in normal (5.5 mM) and high glucose (25 mM). Oligomycin was added to astrocyte culture 2 hours before ATP assay (*p<0.05 vs 5.5 mM, n=3). C) Glycogen assay of astrocytes cultured for 72 hours in normal (5.5 mM) and high glucose (25 mM) (*p<0.05 vs 5.5 mM, n=4).

Figure 6.  High glucose activated AMPK pathway

A) Western blots and statistical analysis of AMPK and mTOR pathway in astrocytes after 4-day culture in normal (5.5 mM) and high glucose (25 mM) (*p<0.05 vs 5.5 mM, n=3). B) Western blot and statistical analysis of mTOR, ACC and GS activation after 2-week culture in normal (5.5 mM) and high glucose (25 mM) (*p<0.05 vs 5.5 mM, n=3).

[1] Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH (1998). Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res, 800: 125-135
[2] Manschot SM, Biessels GJ, Cameron NE, Cotter MA, Kamal A, Kappelle LJ, et al. (2003). Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res, 966: 274-282
[3] Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP (2008). Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci, 11: 309-317
[4] Nitta A, Murai R, Suzuki N, Ito H, Nomoto H, Katoh G, et al. (2002). Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol, 24: 695-701
[5] Navaratna D, Guo SZ, Hayakawa K, Wang X, Gerhardinger C, Lo EH (2011). Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes, 60: 1789-1796
[6] Pulsinelli WA, Levy DE, Sigsbee B, Scherer P, Plum F (1983). Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med, 74: 540-544
[7] Pulsinelli WA, Waldman S, Rawlinson D, Plum F (1982). Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology, 32: 1239-1246
[8] Biessels GJ, Reijmer YD (2014). Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes, 63: 2244-2252
[9] Yarchoan M, Arnold SE (2014). Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes, 63: 2253-2261
[10] Tomlinson DR, Gardiner NJ (2008). Glucose neurotoxicity. Nat Rev Neurosci, 9: 36-45
[11] Tomlinson DR, Gardiner NJ (2008). Diabetic neuropathies: components of etiology. J Peripher Nerv Syst, 13: 112-121
[12] Halassa MM, Haydon PG (2010). Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol, 72: 335-355
[13] Magistretti PJ (2006). Neuron-glia metabolic coupling and plasticity. J Exp Biol, 209: 2304-2311
[14] Wang DD, Bordey A (2008). The astrocyte odyssey. Prog Neurobiol, 86: 342-367
[15] Sofroniew MV, Vinters HV (2010). Astrocytes: biology and pathology. Acta Neuropathol, 119: 7-35
[16] Wang J, Li G, Wang Z, Zhang X, Yao L, Wang F, et al. (2012). High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes. Neuroscience, 202: 58-68
[17] Shin ES, Huang Q, Gurel Z, Sorenson CM, Sheibani N (2014). High glucose alters retinal astrocytes phenotype through increased production of inflammatory cytokines and oxidative stress. PLoS One, 9: e103148
[18] Gandhi GK, Ball KK, Cruz NF, Dienel GA (2010). Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro, 2: e00030
[19] Coleman E, Judd R, Hoe L, Dennis J, Posner P (2004). Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia, 48: 166-178
[20] Saravia FE, Revsin Y, Gonzalez Deniselle MC, Gonzalez SL, Roig P, Lima A, et al. (2002). Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res, 957: 345-353
[21] Abbott NJ, Ronnback L, Hansson E (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci, 7: 41-53
[22] Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010). The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia, 58: 1094-1103
[23] Roy Choudhury G, Ryou MG, Poteet E, Wen Y, He R, Sun F, et al. (2014). Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke. Brain Res, 1551: 45-58
[24] Xie L, Choudhury GR, Winters A, Yang SH, Jin K (2015). Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol, 45: 180-191
[25] Rooijackers HM, Wiegers EC, Tack CJ, van der Graaf M, de Galan BE (2016). Brain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studies. Cell Mol Life Sci, 73: 705-722
[26] Jakoby P, Schmidt E, Ruminot I, Gutierrez R, Barros LF, Deitmer JW (2014). Higher transport and metabolism of glucose in astrocytes compared with neurons: a multiphoton study of hippocampal and cerebellar tissue slices. Cereb Cortex, 24: 222-231
[27] Bardehle S, Kruger M, Buggenthin F, Schwausch J, Ninkovic J, Clevers H, et al. (2013). Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci, 16: 580-586
[28] Barreto GE, Sun X, Xu L, Giffard RG (2011). Astrocyte proliferation following stroke in the mouse depends on distance from the infarct. PLoS One, 6: e27881
[29] Jing L, Mai L, Zhang JZ, Wang JG, Chang Y, Dong JD, et al. (2013). Diabetes inhibits cerebral ischemia-induced astrocyte activation - an observation in the cingulate cortex. Int J Biol Sci, 9: 980-988
[30] Jacob RJ, Fan X, Evans ML, Dziura J, Sherwin RS (2002). Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: no evidence for protective adaptation by the blood brain barrier. Metabolism, 51: 1522-1524
[31] Salceda R, Vilchis C, Coffe V, Hernandez-Munoz R (1998). Changes in the redox state in the retina and brain during the onset of diabetes in rats. Neurochem Res, 23: 893-897
[32] De Feyter HM, Mason GF, Shulman GI, Rothman DL, Petersen KF (2013). Increased brain lactate concentrations without increased lactate oxidation during hypoglycemia in type 1 diabetic individuals. Diabetes, 62: 3075-3080
[33] Allaman I, Belanger M, Magistretti PJ (2011). Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci, 34: 76-87
[34] Belanger M, Allaman I, Magistretti PJ (2011). Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab, 14: 724-738
[35] Steinman MQ, Gao V, Alberini CM (2016). The Role of Lactate-Mediated Metabolic Coupling between Astrocytes and Neurons in Long-Term Memory Formation. Front Integr Neurosci, 10: 10
[36] Stobart JL, Anderson CM (2013). Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Front Cell Neurosci, 7: 38
[37] Kraig RP, Petito CK, Plum F, Pulsinelli WA (1987). Hydrogen ions kill brain at concentrations reached in ischemia. J Cereb Blood Flow Metab, 7: 379-386
[38] Lama S, Auer RN, Tyson R, Gallagher CN, Tomanek B, Sutherland GR (2014). Lactate storm marks cerebral metabolism following brain trauma. J Biol Chem, 289: 20200-20208
[39] Kahn BB, Alquier T, Carling D, Hardie DG (2005). AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab, 1: 15-25
[40] Motoshima H, Goldstein BJ, Igata M, Araki E (2006). AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol, 574: 63-71
[41] Lovatt D, Sonnewald U, Waagepetersen HS, Schousboe A, He W, Lin JH, et al. (2007). The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J Neurosci, 27: 12255-12266
[42] Zielke HR, Zielke CL, Baab PJ (2009). Direct measurement of oxidative metabolism in the living brain by microdialysis: a review. J Neurochem, 109 Suppl 1: 24-29
[1] Tseng Chin-Hsiao. Metformin and the Risk of Dementia in Type 2 Diabetes Patients[J]. Aging and disease, 2019, 10(1): 37-48.
[2] Changhong Ren, Hang Wu, Dongjie Li, Yong Yang, Yuan Gao, Yunneng Jizhang, Dachuan Liu, Xunming Ji, Xuxiang Zhang. Remote Ischemic Conditioning Protects Diabetic Retinopathy in Streptozotocin-induced Diabetic Rats via Anti-Inflammation and Antioxidation[J]. Aging and disease, 2018, 9(6): 1122-1133.
[3] Maxime Fournet, Frederic Bonte, Alexis Desmouliere. Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging[J]. Aging and disease, 2018, 9(5): 880-900.
[4] Yang Yao-Chih, Tsai Cheng-Yen, Chen Chien-Lin, Kuo Chia-Hua, Hou Chien-Wen, Cheng Shi-Yann, Aneja Ritu, Huang Chih-Yang, Kuo Wei-Wen. Pkcδ Activation is Involved in ROS-Mediated Mitochondrial Dysfunction and Apoptosis in Cardiomyocytes Exposed to Advanced Glycation End Products (Ages)[J]. Aging and disease, 2018, 9(4): 647-663.
[5] Yan Tao, Venkat Poornima, Chopp Michael, Zacharek Alex, Yu Peng, Ning Ruizhuo, Qiao Xiaoxi, Kelley Mark R., Chen Jieli. APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats[J]. Aging and disease, 2018, 9(3): 453-466.
[6] Zhen Jie, Lin Tong, Huang Xiaochen, Zhang Huiqiang, Dong Shengqi, Wu Yifan, Song Linlin, Xiao Rong, Yuan Linhong. Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study[J]. Aging and disease, 2018, 9(3): 346-357.
[7] Peng Fangyu, Xie Fang, Muzik Otto. Alteration of Copper Fluxes in Brain Aging: A Longitudinal Study in Rodent Using 64CuCl2-PET/CT[J]. Aging and disease, 2018, 9(1): 109-118.
[8] Tia R. Tidwell,Kjetil Søreide,Hanne R. Hagland. Aging, Metabolism, and Cancer Development: from Peto’s Paradox to the Warburg Effect[J]. A&D, 2017, 8(5): 662-676.
[9] Jan R. Aunan,William C Cho,Kjetil Søreide. The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks[J]. A&D, 2017, 8(5): 628-642.
[10] Hong Zheng,Jinzi Wu,Zhen Jin,Liang-Jun Yan. Potential Biochemical Mechanisms of Lung Injury in Diabetes[J]. A&D, 2017, 8(1): 7-16.
[11] Xiaoting Luo,Jinzi Wu,Siqun Jing,Liang-Jun Yan. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity[J]. A&D, 2016, 7(1): 90-110.
[12] Xu Yunqi, Wei Xiaobo, Liu Xu, Liao Jinchi, Lin Jiaping, Zhu Cansheng, Meng Xiaochun, Xie Dongsi, Chao Dongman, J Fenoy Albert, Cheng Muhua, Tang Beisha, Zhang Zhuohua, Xia Ying, Wang Qing. Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease[J]. A&D, 2015, 6(6): 426-436.
[13] João M N. Duarte. Metabolic Alterations Associated to Brain Dysfunction in Diabetes[J]. A&D, 2015, 6(5): 304-321.
[14] Yi Zhou,Rong Fang,Li-Hua Liu,Sheng-Di Chen,Hui-Dong Tang. Clinical Characteristics for the Relationship between Type-2 Diabetes Mellitus and Cognitive Impairment: A Cross-Sectional Study[J]. A&D, 2015, 6(4): 236-244.
[15] Ahmed H Abdelhafiz,Alan J Sinclair. Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor?[J]. A&D, 2015, 6(4): 262-270.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd